US Stock MarketDetailed Quotes

Sana Biotechnology (SANA)

Watchlist
  • 3.070
  • -0.070-2.23%
Close May 15 16:00 ET
  • 3.040
  • -0.030-0.98%
Post 20:01 ET
854.36MMarket Cap-3.34P/E (TTM)

Sana Biotechnology (SANA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.18%-37.38M
35.55%-143.83M
30.79%-32.64M
43.21%-29.43M
43.46%-33.1M
25.86%-48.66M
12.00%-223.15M
9.23%-47.16M
18.46%-51.82M
0.44%-58.54M
Net income from continuing operations
4.41%-47.21M
8.47%-244.17M
-19.88%-58.83M
29.66%-42.15M
-86.51%-93.8M
54.05%-49.39M
5.82%-266.76M
44.31%-49.07M
-6,189.84%-59.92M
55.88%-50.29M
Depreciation and amortization
-34.48%2.39M
-17.74%12.75M
-19.70%3.05M
-21.35%3.19M
-26.65%2.86M
-2.59%3.65M
-11.65%15.5M
-10.54%3.8M
-9.82%4.06M
-12.43%3.9M
Other non cash items
801.63%8.29M
368.80%27.63M
192.33%13.38M
152.67%3.36M
138.53%9.97M
-97.48%919K
79.04%-10.28M
-315.69%-14.49M
92.34%-6.38M
-196.17%-25.87M
Change In working capital
40.06%-6.51M
-753.50%-10.11M
-20.07%3.41M
302.62%697K
-243.34%-3.37M
-45.53%-10.86M
-106.37%-1.19M
-58.31%4.27M
-106.64%-344K
-83.22%2.35M
-Change in prepaid assets
19.01%1.63M
133.16%1.17M
-121.30%-696K
65.34%1.12M
87.64%-628K
157.48%1.37M
-143.14%-3.51M
26.52%3.27M
413.64%678K
-191.78%-5.08M
-Change in payables and accrued expense
49.38%-6.64M
-18.09%-8.28M
845.38%5.57M
187.11%1.03M
-130.43%-1.77M
-20.51%-13.12M
-1,328.31%-7.01M
36.10%-747K
-127.22%-1.19M
-17.19%5.81M
-Change in other working capital
-267.90%-1.5M
-132.08%-3M
-183.31%-1.46M
-983.64%-1.46M
-159.93%-972K
-84.65%891K
-14.76%9.34M
-80.18%1.75M
-75.91%165K
11.71%1.62M
Cash from discontinued investing activities
Operating cash flow
23.18%-37.38M
35.55%-143.83M
30.79%-32.64M
43.21%-29.43M
43.46%-33.1M
25.86%-48.66M
12.00%-223.15M
9.23%-47.16M
18.46%-51.82M
0.44%-58.54M
Investing cash flow
Cash flow from continuing investing activities
197.76%49.44M
-330.55%-40.24M
-135.03%-16.5M
-214.96%-48.03M
32.00%7.68M
121.50%16.6M
-89.85%17.45M
207.56%47.09M
-18.64%41.78M
-86.35%5.82M
Net PPE purchase and sale
-111.76%-288K
97.19%-938K
-100.23%-873K
99.00%-41K
100.86%112K
99.14%-136K
-66.88%-33.43M
96.90%-436K
-83.30%-4.09M
-727.90%-13.06M
Net investment purchase and sale
200.12%49.48M
-180.05%-40.73M
-134.26%-16.28M
-204.91%-48.12M
-61.93%7.19M
126.86%16.49M
-73.50%50.88M
61.89%47.52M
-14.40%45.87M
-57.30%18.87M
Net other investing changes
-1.98%248K
--1.43M
--661K
--136K
--382K
--253K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
197.76%49.44M
-330.55%-40.24M
-135.03%-16.5M
-214.96%-48.03M
32.00%7.68M
121.50%16.6M
-89.85%17.45M
207.56%47.09M
-18.64%41.78M
-86.35%5.82M
Financing cash flow
Cash flow from continuing financing activities
-113.03%-128K
-35.55%128.73M
2,644.95%17.65M
5,161.29%109.54M
-94.72%561K
-99.47%982K
531.20%199.75M
-62.57%643K
1,013.37%2.08M
-63.98%10.63M
Net issuance payments of debt
-7.06%-91K
-33.21%126.06M
----
----
----
---85K
598.53%188.74M
----
----
----
Net common stock issuance
----
----
----
377,582.76%109.47M
171.53%314K
-100.03%-60K
569.87%181M
--0
-480.00%-29K
-101.63%-439K
Proceeds from stock option exercised by employees
-94.76%59K
-75.68%2.68M
51.50%1.06M
-91.90%157K
-90.31%333K
-77.14%1.13M
137.89%11.01M
-59.05%699K
909.90%1.94M
38.02%3.44M
Net other financing activities
-60.00%-96K
----
----
-150.58%-87K
---111K
---60K
----
----
--172K
----
Cash from discontinued financing activities
Financing cash flow
-113.03%-128K
-35.55%128.73M
2,644.95%17.65M
5,161.29%109.54M
-94.72%561K
-99.47%982K
531.20%199.75M
-62.57%643K
1,013.37%2.08M
-63.98%10.63M
Net cash flow
Beginning cash position
-42.11%76.07M
-4.33%131.4M
-17.79%107.55M
-45.63%75.47M
-44.54%100.33M
-4.33%131.4M
-26.66%137.35M
-24.06%130.83M
-24.69%138.79M
5.80%180.89M
Current changes in cash
138.39%11.93M
-829.81%-55.33M
-5,624.04%-31.49M
502.99%32.09M
40.94%-24.86M
-171.37%-31.07M
88.08%-5.95M
101.63%570K
33.73%-7.96M
-415.78%-42.1M
End cash Position
-12.29%88M
-42.11%76.07M
-42.11%76.07M
-17.79%107.55M
-45.63%75.47M
-44.54%100.33M
-4.33%131.4M
-4.33%131.4M
-24.06%130.83M
-24.69%138.79M
Free cash flow
22.80%-37.67M
43.58%-144.77M
29.59%-33.51M
47.29%-29.47M
53.92%-32.99M
40.11%-48.79M
6.22%-256.58M
27.89%-47.6M
15.01%-55.91M
-18.58%-71.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.18%-37.38M35.55%-143.83M30.79%-32.64M43.21%-29.43M43.46%-33.1M25.86%-48.66M12.00%-223.15M9.23%-47.16M18.46%-51.82M0.44%-58.54M
Net income from continuing operations 4.41%-47.21M8.47%-244.17M-19.88%-58.83M29.66%-42.15M-86.51%-93.8M54.05%-49.39M5.82%-266.76M44.31%-49.07M-6,189.84%-59.92M55.88%-50.29M
Depreciation and amortization -34.48%2.39M-17.74%12.75M-19.70%3.05M-21.35%3.19M-26.65%2.86M-2.59%3.65M-11.65%15.5M-10.54%3.8M-9.82%4.06M-12.43%3.9M
Other non cash items 801.63%8.29M368.80%27.63M192.33%13.38M152.67%3.36M138.53%9.97M-97.48%919K79.04%-10.28M-315.69%-14.49M92.34%-6.38M-196.17%-25.87M
Change In working capital 40.06%-6.51M-753.50%-10.11M-20.07%3.41M302.62%697K-243.34%-3.37M-45.53%-10.86M-106.37%-1.19M-58.31%4.27M-106.64%-344K-83.22%2.35M
-Change in prepaid assets 19.01%1.63M133.16%1.17M-121.30%-696K65.34%1.12M87.64%-628K157.48%1.37M-143.14%-3.51M26.52%3.27M413.64%678K-191.78%-5.08M
-Change in payables and accrued expense 49.38%-6.64M-18.09%-8.28M845.38%5.57M187.11%1.03M-130.43%-1.77M-20.51%-13.12M-1,328.31%-7.01M36.10%-747K-127.22%-1.19M-17.19%5.81M
-Change in other working capital -267.90%-1.5M-132.08%-3M-183.31%-1.46M-983.64%-1.46M-159.93%-972K-84.65%891K-14.76%9.34M-80.18%1.75M-75.91%165K11.71%1.62M
Cash from discontinued investing activities
Operating cash flow 23.18%-37.38M35.55%-143.83M30.79%-32.64M43.21%-29.43M43.46%-33.1M25.86%-48.66M12.00%-223.15M9.23%-47.16M18.46%-51.82M0.44%-58.54M
Investing cash flow
Cash flow from continuing investing activities 197.76%49.44M-330.55%-40.24M-135.03%-16.5M-214.96%-48.03M32.00%7.68M121.50%16.6M-89.85%17.45M207.56%47.09M-18.64%41.78M-86.35%5.82M
Net PPE purchase and sale -111.76%-288K97.19%-938K-100.23%-873K99.00%-41K100.86%112K99.14%-136K-66.88%-33.43M96.90%-436K-83.30%-4.09M-727.90%-13.06M
Net investment purchase and sale 200.12%49.48M-180.05%-40.73M-134.26%-16.28M-204.91%-48.12M-61.93%7.19M126.86%16.49M-73.50%50.88M61.89%47.52M-14.40%45.87M-57.30%18.87M
Net other investing changes -1.98%248K--1.43M--661K--136K--382K--253K----------------
Cash from discontinued investing activities
Investing cash flow 197.76%49.44M-330.55%-40.24M-135.03%-16.5M-214.96%-48.03M32.00%7.68M121.50%16.6M-89.85%17.45M207.56%47.09M-18.64%41.78M-86.35%5.82M
Financing cash flow
Cash flow from continuing financing activities -113.03%-128K-35.55%128.73M2,644.95%17.65M5,161.29%109.54M-94.72%561K-99.47%982K531.20%199.75M-62.57%643K1,013.37%2.08M-63.98%10.63M
Net issuance payments of debt -7.06%-91K-33.21%126.06M---------------85K598.53%188.74M------------
Net common stock issuance ------------377,582.76%109.47M171.53%314K-100.03%-60K569.87%181M--0-480.00%-29K-101.63%-439K
Proceeds from stock option exercised by employees -94.76%59K-75.68%2.68M51.50%1.06M-91.90%157K-90.31%333K-77.14%1.13M137.89%11.01M-59.05%699K909.90%1.94M38.02%3.44M
Net other financing activities -60.00%-96K---------150.58%-87K---111K---60K----------172K----
Cash from discontinued financing activities
Financing cash flow -113.03%-128K-35.55%128.73M2,644.95%17.65M5,161.29%109.54M-94.72%561K-99.47%982K531.20%199.75M-62.57%643K1,013.37%2.08M-63.98%10.63M
Net cash flow
Beginning cash position -42.11%76.07M-4.33%131.4M-17.79%107.55M-45.63%75.47M-44.54%100.33M-4.33%131.4M-26.66%137.35M-24.06%130.83M-24.69%138.79M5.80%180.89M
Current changes in cash 138.39%11.93M-829.81%-55.33M-5,624.04%-31.49M502.99%32.09M40.94%-24.86M-171.37%-31.07M88.08%-5.95M101.63%570K33.73%-7.96M-415.78%-42.1M
End cash Position -12.29%88M-42.11%76.07M-42.11%76.07M-17.79%107.55M-45.63%75.47M-44.54%100.33M-4.33%131.4M-4.33%131.4M-24.06%130.83M-24.69%138.79M
Free cash flow 22.80%-37.67M43.58%-144.77M29.59%-33.51M47.29%-29.47M53.92%-32.99M40.11%-48.79M6.22%-256.58M27.89%-47.6M15.01%-55.91M-18.58%-71.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More